Status:
COMPLETED
Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul
Lead Sponsor:
Waisenmedizin e. V. Promoting Access to Essential Medicine
Collaborating Sponsors:
German Medical Service (GMS) in Kabul
University of Freiburg
Conditions:
Wound Healing
Eligibility:
All Genders
5-99 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of the randomized double blind trial with 134 patients presenting old world cutaneous leishmaniasis is: * to evaluate the clinical efficacy of electro-thermo-cauterisation (ETC) followed by m...
Eligibility Criteria
Inclusion
- at least one suspected lesion positive in Giemsa smear
Exclusion
- patients previously treated for leishmania
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2007
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT00947362
Start Date
August 1 2004
End Date
December 15 2007
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
German Medical Service
Kabul, Kabul, Afghanistan